Jabi Osama, Lan Nan, Pokala Akshay, Kiran Ravi P, Shen Bo
The Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
Gastroenterol Rep (Oxf). 2024 May 16;12:goae038. doi: 10.1093/gastro/goae038. eCollection 2024.
Strictures are a common complication after ileal pouch surgery with the most common locations being at the anastomosis, pouch inlet, and stoma closure site. No previous literature has described endoscopic therapy of stoma site stricture. This study aimed to assess the safety and efficacy of endoscopic therapy in the treatment of stoma closure site strictures.
Patients diagnosed with stoma closure site strictures following ileal pouch surgery who underwent endoscopic treatment at the Center for Colorectal Diseases, Inflammatory Bowel Disease (IBD), and Ileal Pouch between 2018 and 2022 were analysed. Primary outcomes (technical success and surgery-free survival) were compared between endoscopic balloon dilation (EBD) and stricturotomy and/or strictureplasty.
A total of 30 consecutive eligible patients were analysed. Most patients were female (66.7%) and most patients were diagnosed with IBD (93.3%). Twenty patients (66.7%) had end-to-end anastomosis. A total of 52 procedures were performed, with EBD in 16 (30.8%) and stricturotomy and/or strictureplasty in 36 (69.2%). The mean stricture length was 1.7 ± 1.0 cm. Immediate technical success was achieved in 47 of 52 interventions (90.4%). During a mean follow-up of 12.7 ± 9.9 months, none of the patients underwent surgical intervention for the stricture. Fourteen (46.7%) required endoscopic re-intervention for their strictures with an interval between index and re-interventional pouchoscopy of 8.8 ± 6.3 months. Post-procedural complications were reported in 2 (6.7%) with bleeding and none with perforation. Upon follow-up, 20 (66.7%) patients reported improvement in their symptoms.
EBD and endoscopic stricturotomy and/or strictureplasty are safe and effective in treating stoma closure site strictures in patients with ileal pouches, providing symptomatic relief in most patients as well as avoiding surgery.
狭窄是回肠储袋手术后的常见并发症,最常见的部位是吻合口、储袋入口和造口闭合处。此前尚无文献描述造口部位狭窄的内镜治疗。本研究旨在评估内镜治疗造口闭合处狭窄的安全性和有效性。
对2018年至2022年间在结直肠疾病、炎症性肠病(IBD)和回肠储袋中心接受内镜治疗的回肠储袋手术后诊断为造口闭合处狭窄的患者进行分析。比较内镜球囊扩张术(EBD)与狭窄切开术和/或狭窄成形术的主要结局(技术成功率和无手术生存率)。
共分析了30例连续符合条件的患者。大多数患者为女性(66.7%),大多数患者诊断为IBD(93.3%)。20例患者(66.7%)进行了端端吻合。共进行了52次手术,其中EBD 16次(30.8%),狭窄切开术和/或狭窄成形术36次(69.2%)。平均狭窄长度为1.7±1.0厘米。52次干预中有47次(90.4%)立即取得技术成功。在平均12.7±9.9个月的随访期间,没有患者因狭窄接受手术干预。14例(46.7%)患者因狭窄需要内镜再次干预,初次与再次干预性储袋镜检查的间隔时间为8.8±6.3个月。术后并发症报告2例(6.7%),为出血,无穿孔。随访时20例(66.7%)患者报告症状改善。
EBD以及内镜狭窄切开术和/或狭窄成形术在治疗回肠储袋患者的造口闭合处狭窄方面安全有效,可为大多数患者缓解症状并避免手术。